Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Nov 11;94(23):12551-6.
doi: 10.1073/pnas.94.23.12551.

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin

Affiliations

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin

J Olweus et al. Proc Natl Acad Sci U S A. .

Abstract

Dendritic cells (DC) have been thought to represent a family of closely related cells with similar functions and developmental pathways. The best-characterized precursors are the epidermal Langerhans cells, which migrate to lymphoid organs and become activated DC in response to inflammatory stimuli. Here, we demonstrate that a large subset of DC in the T cell-dependent areas of human lymphoid organs are nonactivated cells and belong to a separate lineage that can be identified by high levels of the interleukin 3 receptor alpha chain (IL-3Ralphahi). The CD34+IL-3Ralphahi DC progenitors are of myeloid origin and are distinct from those that give rise to Langerhans cells in vitro. The IL-3Ralphahi DC furthermore appear to migrate to lymphoid organs independently of inflammatory stimuli or foreign antigens. Thus, DC are heterogeneous with regard to function and ontogeny.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antibodies to IL-3Rα selectively stain DC in extrafollicular regions of human tonsils. (AC) Tonsillar mononuclear cells were stained with anti-HLA-DR peridinin-chlorophyll protein (PerCP), CD4 PE, anti-IL-3Rα biotin + Streptavidin allo-phycocyanin (ALPC), and a mixture of FITC-conjugated lineage markers (“lin”) for lymphocytes and monocytes (CD3, CD14, CD16, CD19, CD20, CD56, and goat-anti-human IgM). The cells were analyzed by four-color flow cytometry. Dendritic cells were identified as HLA-DR+CD4+lin—i.e., cells that simultaneously satisfy the criteria of the box regions in A and B, and are represented by large black dots. Dashed lines represent isotype control levels. (D) Wright–Giemsa staining of a cytocentrifuge slide of freshly FACS-sorted tonsillar HLA-DR+linIL-3Rαhi cells. (×600.) (E) FACS-sorted tonsillar HLA-DR+linIL-3Rαhi cells were cultured for 24 h with GM-CSF and IL-3 and photographed in situ. (×400.) (F) A frozen section of tonsillar tissue was stained with anti-IL-3Rα, biotinylated anti-mouse IgG and streptavidin peroxidase. (×100). Staining was visualized by diaminobenzidine and hydrogen-peroxide, and the section was counterstained with methylene blue.
Figure 2
Figure 2
IL-3Rαhi DC are immature and appear in lymphoid organs independently of stimuli that cause up-regulation of major histocompatibility complex class II and costimulatory molecules. (A) Mononuclear cells from tonsil were stained with anti-HLA-DR, anti-IL-3Rα and lineage markers, and either CD86, CD80, HLA-DQ, or isotype control mAbs before (open bars) and after (filled bars) a 16-h incubation at 37°C in Yssel’s medium (30). The HLA-DR+linIL-3Rαhi population was analyzed for mean fluorescence intensity (MFI) staining with the markers indicated on the figure, and the bars represent MFI after isotype control levels were subtracted. (B) T cells (105) were cocultured with indicated numbers of allogeneic IL-3RαhilinHLA-DR+ cells from tonsil (stimulator cells). T cell proliferation was measured as the total number of CD3+ BrdU+ cells per well at day 6 of coculture. (C) Fetal lymph node cells were stained with anti-HLA-DR, anti-IL-3Rα, and lineage markers (data not shown) and analyzed by flow cytometry as described in Fig. 1 AC. Data are representative of three experiments.
Figure 3
Figure 3
HLA-DR+linIL-3Rαhi DC are present in peripheral blood. (A and B) PBMC were stained with anti-HLA-DR, anti-IL-3Rα, and lineage markers (not shown) and analyzed by flow cytometry as described in Fig. 1 AC. R1 and R2 in B represent regions used to sort IL-3Rαhi blood cells that were positive or negative for HLA-DR, respectively. (C and D) HLA-DR+linIL-3Rαhi cells sorted from blood according to R1 in B were first cultured separately with IL-3 and GM-CSF for 36 h and then incubated with allogeneic (C) or autologous (D) CD4+ T cells. T cell proliferation was measured as total number of CD3+BrdU+ cells per well at day 6 of coculture with indicated numbers of IL-3RαhilinHLA-DR+ cells (▪) or CD14hi monocytes (○) from the same donor (stimulator cells). Individual displays show data that are representative of three experiments. OLS, ortogonal light scatter.
Figure 4
Figure 4
Proliferating progenitors for IL-3Rαhi DC are found as a discrete CD34+IL-3Rαhi population that is distinct from the cells that give rise to Langerhans cells in response to GM-CSF and TNF-α. (A and B) Isolated CD34+ fetal bone marrow cells were stained with CD34 and anti-IL-3Rα. The cells were analyzed by flow cytometry as described in Fig. 1 AC. The CD34+IL-3Rαhi population was defined according to the region in A (blue dots). CD34+IL-3Rαlo cells were defined according to the region in B (red dots). OLS, ortogonal light scatter. (C) Freshly sorted Wright–Giemsa-stained CD34+IL-3Rαhi cells display mitotic figures. (×600.) (DG) CD34+IL-3Rαhi cells (blue) and CD34+IL-3Rαlo cells (red) were sorted according to the regions in A and B, respectively, and cultured in the presence of indicated cytokines, stained with CD1a and CD45RA after 5 days of culture, and analyzed by FACS. L = B lymphoid cells staining brightly with CD19 (data not shown). None of the cultured CD34+IL-3Rαhi cells (D and E) stained positively with CD19 (data not shown). Dashed lines indicate isotype control levels. (H) Transmission electron microscograph (×5,000) of a CD1a+ cell sorted from CD34+IL-3Rαlo cells cultured with GM-CSF and TNF-α, as described in G. The arrows point to areas containing Birbeck granules, (shown in Insets, ×45,000). (I) CD4+ T cells (105) were cocultured with indicated numbers of allogeneic DC (▪) or macrophages (○) from the same donor. The DC were generated by culturing sorted CD34+IL-3Rαhi cells for 5 days with GM-CSF and IL-3 (▪). The macrophages were generated by culture of CD34+M-CSFR+ cells for 5 days with M-CSF and purified by FACS sorting of CD14+ cells. T cell proliferation was measured as incorporation of [3H]thymidine at day 6 of coculture. c.p.m; counts per minute. Data are representative of three experiments.
Figure 5
Figure 5
IL-3Rαhi DC follow the myeloid differentiation pathway to the branching point of the granulocytic and monocytic lineages. (A) CD34+ cells were incubated for 12 h in serum-free medium (25) to allow up-regulation of the M-CSFR, and stained with CD34, anti-M-CSFR, and anti-IL-3Rα. The arrow shows the suggested differentiation pathway of CD34+IL-3Rαhi cells. The region shows sorting criteria for M-CSFRhi/IL-3Rαlo cells. An additional gate was set to include only CD34hi cells, shown in Fig. 4B, to restrict the sort to immature progenitors (29). (B) After a 60-h culture of CD34hiM-CSFR+ cells in serum-free medium (25) containing stem cell factor, G-CSF, GM-CSF, IL-3, and IL-6, the cells were stained with anti-M-CSFR and anti-IL-3Rα. The regions indicate criteria for sorting of the two populations that had downmodulated the M-CSFR during the culture period. (C and D) After a 5-day secondary culture of IL-3RαloM-CSFRlo cells (green) and IL-3RαhiM-CSFRlo cells (blue) with IL-3 and GM-CSF, the cells were stained with CD1a and CD15 and analyzed by FACS. The small subset of CD15lo cells in C represent basophilic granulocytes (27, 29).

References

    1. Steinman R M. Annu Rev Immunol. 1991;9:271–296. - PubMed
    1. Schuler G, Steinman R. J Exp Med. 1985;161:526–546. - PMC - PubMed
    1. Silberberg-Sinakin I, Thorbecke J, Baer R, Rosenthal S, Berezowsky V. Cell Immunol. 1976;25:137–151. - PubMed
    1. Macatonia S, Knight S, Edwards A, Griffiths S, Fryer P. J Exp Med. 1987;166:1654–1667. - PMC - PubMed
    1. Kripke M, Munn C, Jeevan A, Tang J, Bucana C. J Immunol. 1990;145:2833–2838. - PubMed

Publication types

LinkOut - more resources